OKYO Pharma Strengthens Scientific Advisory Board With Marta Sacchetti Appointment

OKYO Pharma’s CEO Robert Dempsey joined Steve Darling from Proactive to announce the appointment of Dr. Marta Sacchetti, MD, PhD, as the newest member of the company’s Scientific Advisory Board (SAB), a move designed to further strengthen the company’s scientific and clinical expertise as it advances its lead ophthalmic programs. Dempsey explained that Sacchetti’s addition enhances OKYO Pharma’s already distinguished global network of scientific and medical advisors. Widely recognized for her expertise in neuro-inflammatory corneal diseases, Sacchetti brings deep knowledge and extensive research experience that aligns with the company’s mission to address significant unmet needs in ophthalmology and ocular surface disease treatment. Sacchetti currently serves as an Associate Professor of Ophthalmology at Link University in Rome, Italy, and has built a strong reputation through her work spanning clinical practice, research, and industry collaboration. Her previous experience as Gl...